CVS Health Corporation reported second-quarter 2025 financial results, noting higher revenues but lower operating income, influenced by litigation charges. The company also updated its full-year 2025 guidance.
For the three months ended June 30, total revenues rose 8.4% compared to the same period in 2024. Growth was reported across all operating segments. Operating income declined 21.8%, primarily due to $833 million in litigation charges tied to two court rulings on past business practices.
Adjusted operating income rose 1.7%, supported by gains in the healthcare benefits segment and partially offset by a decrease in the health services segment. Interest expense climbed $31 million, or 4.2%, driven by higher debt levels stemming from long-term debt issued in December 2024.
CVS Health said it plans to allocate $20 billion over the next decade to streamline the US health system. The initiative aims to improve interoperability among members, caregivers, providers, and community organizations, with the goal of enhancing collaboration and patient outcomes.
The company announced executive appointments during the quarter. Brian Newman joined as executive vice president and chief financial officer, having previously served in the same roles at United Parcel Service.
Amy Compton-Phillips, MD, was named executive vice president and chief medical officer, previously holding the role of chief physician executive at Press Ganey.
“Our strong performance demonstrates the continued focus we have on operational and financial improvement across our businesses, led by a significant and durable recovery at Aetna, strong retention at CVS Caremark and growth and momentum at CVS Pharmacy,” David Joyner (pictured above), CVS Health president and CEO said.
CVS Health confirmed earlier this year that it would exit the Affordable Care Act individual exchange market. The decision followed ongoing underperformance and limited future profitability projections in that segment, adding pressure to its Health Care Benefits business.
Aetna, a CVS Health business, continues to maintain an A (Excellent) rating from AM Best, reflecting financial strength across its insurance operations. This rating supports the unit’s stability in providing pharmacy benefit management and health plan services, even as it navigates regulatory scrutiny and market shifts.
The company also reported ongoing cost pressures within its Aetna unit, driven by rising medical expenses and lower Medicare star ratings compared to prior years. These factors have weighed on profitability in the Health Care Benefits segment.
Revenue in the healthcare benefits segment reached $36.3 billion in the second quarter, up from $32.5 billion in the same period in 2024. Adjusted operating income totaled $1.3 billion, compared with $938 million a year earlier. The medical benefit ratio was 89.9%, slightly higher than 89.6% in 2024. Medical membership stood at 26.7 million, down from 27.0 million last year.
For the first six months of 2025, total revenue for the segment was $71.1 billion, up from $64.7 billion in 2024. Adjusted operating income rose to $3.3 billion from $1.7 billion over the same period. The medical benefit ratio improved to 88.6% from 90.0%.
What are your thoughts on this story? Please feel free to share your comments below.
